{
  "trial_id": "NCT00686712",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of type 2 diabetes, current oral diabetes medications, hemoglobin A1c, body mass index (BMI), ethnicity, history of gestational diabetes, history of hospitalizations for diabetes, presence of proliferative diabetic retinopathy, renal function, hepatic function, cardiovascular health, neurological health, endocrinological health, systemic disease status, night shift work status, meal schedule consistency, use of contraception (for females of childbearing potential), pregnancy status, lactation status, participation in other investigational studies, compliance with study protocol.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Hemoglobin A1c",
          "hemoglobin A1c"
        ],
        [
          "Diabetes Duration",
          "duration of type 2 diabetes"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "current oral diabetes medications",
        "history of gestational diabetes",
        "history of hospitalizations for diabetes",
        "presence of proliferative diabetic retinopathy",
        "renal function",
        "hepatic function",
        "cardiovascular health",
        "neurological health",
        "endocrinological health",
        "systemic disease status",
        "night shift work status",
        "meal schedule consistency",
        "use of contraception (for females of childbearing potential)",
        "pregnancy status",
        "lactation status",
        "participation in other investigational studies",
        "compliance with study protocol."
      ]
    },
    "processed-gen-response": "Age, gender, duration of type 2 diabetes, current oral diabetes medications, hemoglobin A1c, body mass index (BMI), ethnicity, history of gestational diabetes, history of hospitalizations for diabetes, presence of proliferative diabetic retinopathy, renal function, hepatic function, cardiovascular health, neurological health, endocrinological health, systemic disease status, night shift work status, meal schedule consistency, use of contraception (for females of childbearing potential), pregnancy status, lactation status, participation in other investigational studies, compliance with study protocol."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Use of Oral Hypoglycemic Agents,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Hemoglobin A1c",
          "Baseline HbA1c"
        ],
        [
          "Diabetes Duration",
          "Duration of Diabetes"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose",
        "Use of Oral Hypoglycemic Agents"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Use of Oral Hypoglycemic Agents"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Body Mass Index, Duration of Diabetes, Hemoglobin A1c, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Hemoglobin A1c",
          "Hemoglobin A1c"
        ],
        [
          "Diabetes Duration",
          "Duration of Diabetes"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Ethnicity (NIH/OMB), Body Mass Index, Duration of Diabetes, Hemoglobin A1c, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, hemoglobin A1c, type and dose of oral agents, sulfonylurea use, metformin use, thiazolidinedione use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Hemoglobin A1c",
          "hemoglobin A1c"
        ],
        [
          "Diabetes Duration",
          "duration of type 2 diabetes"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "type and dose of oral agents",
        "sulfonylurea use",
        "metformin use",
        "thiazolidinedione use."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, hemoglobin A1c, type and dose of oral agents, sulfonylurea use, metformin use, thiazolidinedione use."
  }
}